Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in ≥ 2nd complete remission induced by highly intensive chemotherapy

Haematologica

Volumn 87, Issue 7, 2002, Pages 782-784

  Mengarelli, Andrea ^a   Iori, Anna Paola ^a   Cerretti, Raffaella ^a   Cerilli, Lorenza ^a   Romano, Atelda ^a   Arcese, William ^a  

^a Cattedra di Ematologia   (Italy)

Author keywords

Adult acute lymphoblastic leukemia; Allogeneic stem cell transplantation; Leukemia relapse; Multi drug resistance

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ALLOTRANSPLANTATION; FEMALE; LETTER; MALE; METHODOLOGY; MULTIDRUG RESISTANCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036070536     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. The GIMEMA ALL 0183 trial: Analysis of 10-year follow-up
2. Treatment of adult acute lymphoblastic leukemia (ALL): Long-term follow-up of the GIMEMA ALL 0288 randomized study
3. Adult acute lymphoblastic leukemia: Results of the GIMEMA ALL0394 study
4. Interim analysis of the GIMEMA ALL 0496 trial for adult acute lymphoblastic leukemia (ALL)
5. High-dose idarubicin and cytarabine as salvage treatment for resistant or relapsed adult acute lymphoblastic leukemia: The ALL RESCUE-97 GIMEMA Study
6. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line
7. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia
8. Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia
9. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia
10. Hematopoietic cell transplantation in acute lymphoblastic leukemia: Better long term event-free survival with conditioning regimens containing total body irradiation
11. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation
12. Acute lymphoblastic leukemia in the elderly. A twelve-year retrospective, single center study
13. Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia
14. Karyotype and prognosis in adult Spanish acute lymphoblastic leukemia
15. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia